GLI1 and breast cancer: GLI1 knockdown in claudin-low cells reduced tumor growth of orthotopic xenografts, and treatment with nuclear factor κB (NF-κB) pathway inhibitor decreases GLI1 expression and protein levels in breast cancer [76].